Dark

ISRG
Intuitive Surgical Inc.
stock NASDAQ

At Close

May 9, 2025 3:59:54 PM EDT

536.65USD-0.281%(-1.51)924,941

533.10Bid 560.00Ask 26.90Spread

Pre-market

May 9, 2025 9:07:30 AM EDT

542.40USD+0.788%(+4.24)172

After-hours

May 9, 2025 4:06:30 PM EDT

536.51USD-0.045%(-0.24)6,708

OverviewOptionsHistoricalExchangesShortsNews

Jan 31, 2022

10:29AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022 Benzinga

10:28AM EST Expert Ratings For Intuitive Surgical Benzinga

07:49AM EST 10 Biggest Price Target Changes For Monday Benzinga

05:36AM EST Piper Sandler Upgrades Intuitive Surgical to Overweight, Raises Price Target to $310 Benzinga

Jan 25, 2022

10:03AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 25, 2022 Benzinga

07:49AM EST Redburn Partners Downgrades Intuitive Surgical to Neutral Benzinga

Jan 21, 2022

02:16PM EST If You Invested $100 In This Stock 10 Years Ago, Here's How Much You Would Have Today Benzinga

10:12AM EST Deutsche Bank Maintains Hold on Intuitive Surgical, Lowers Price Target to $300 Benzinga

10:06AM EST Piper Sandler Maintains Neutral on Intuitive Surgical, Lowers Price Target to $300 Benzinga

10:05AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 21, 2022 Benzinga

08:59AM EST Morgan Stanley Maintains Equal-Weight on Intuitive Surgical, Lowers Price Target to $325 Benzinga

08:58AM EST Wells Fargo Maintains Overweight on Intuitive Surgical, Lowers Price Target to $350 Benzinga

08:09AM EST Raymond James Maintains Outperform on Intuitive Surgical, Lowers Price Target to $334 Benzinga

08:08AM EST The Daily Biotech Pulse: Kura Lifts Clinical Hold On Blood Cancer Trial, Intuitive Surgical Earnings, Sorrento's Omicron Antibody Treatment Effective Benzinga

07:35AM EST 10 Biggest Price Target Changes For Friday Benzinga

07:29AM EST Citigroup Upgrades Intuitive Surgical to Buy, Lowers Price Target to $360 Benzinga

05:27AM EST A Peek Into The Markets: US Stock Futures Mostly Lower; Netflix Shares Tumble Following Q4 Results Benzinga

05:20AM EST Intuitive Surgical: Q4 Earnings Insights Benzinga

05:19AM EST Intuitive Surgical Q4 EPS $1.30 Beats $1.28 Estimate, Sales $1.55B Beat $1.52B Estimate Benzinga

Jan 20, 2022

04:32PM EST Intuitive Surgical Inc. (ISRG) released earnings for its fourth quarter that increased from the same period last year and beat the Street estimates. RTTNews

04:10PM EST Intuitive Q4 EPS $1.04 Vs. $1.01 Year Ago RTTNews

04:05PM EST Intuitive (the Company) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December31, 2021. Reported revenue and procedure results are consistent with the Companys press release issued on January 12, 2022. GlobeNewswire Inc

03:40AM EST Earnings Scheduled For January 20, 2022 Benzinga

Jan 19, 2022

10:03AM EST Earnings Preview: Intuitive Surgical Benzinga

Jan 16, 2022

04:38PM EST The Week Ahead In Biotech (Jan 16-22): Focus On Data Presentations And IPOs In Holiday-Shortened Week Benzinga

Jan 12, 2022

09:03AM EST Intuitive Surgical Sees Q4 Sales ~$1.55B vs $1.51B Estimate; FY21 Sales ~$5.71B vs $5.68B Est. Benzinga

09:00AM EST Intuitive (the Company) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2021 financial results ahead of its participation at the 40th Annual J.P. Morgan Healthcare Conference occurring January 10-13, 2022. GlobeNewswire Inc

Jan 10, 2022

01:05PM EST What 4 Analyst Ratings Have To Say About Intuitive Surgical Benzinga

10:06AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2022 Benzinga

07:08AM EST BTIG Upgrades Intuitive Surgical to Buy, Announces $372 Price Target Benzinga

Jan 7, 2022

01:05PM EST Morgan Stanley Maintains Equal-Weight on Intuitive Surgical, Raises Price Target to $375 Benzinga

Dec 15, 2021

08:45AM EST Intuitive Receives FDA Clearance For 8 mm SureForm 30 Curved-Tip Stapler Benzinga

08:45AM EST Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that the U.S. Food & Drug Administration (FDA) cleared the companys fully wristed, 8 mm SureForm 30 Curved-Tip Stapler and reloads (gray, white, and blue) for use in general, thoracic, gynecologic, urologic, and pediatric surgery. GlobeNewswire Inc

Dec 14, 2021

08:46AM EST Intuitive Reaches 10 Million Procedures Performed Using Da Vinci Surgical Systems Benzinga

08:45AM EST Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that the number of robotic-assisted surgical procedures performed worldwide by surgeons using da Vinci surgical systems has surpassed 10 million. GlobeNewswire Inc

Oct 21, 2021

12:12PM EDT Morgan Stanley Maintains Equal-Weight on Intuitive Surgical, Raises Price Target to $325 Benzinga

Oct 20, 2021

10:34AM EDT Abbot Labs and Biogen Outshine Novavax in the Health Care Sector Benzinga

10:29AM EDT A Crowded Earnings Calendar Ahead Benzinga

07:56AM EDT Wells Fargo Maintains Overweight on Intuitive Surgical, Raises Price Target to $381 Benzinga

05:58AM EDT Intuitive's Q3 Earnings Slightly Edges Out Expectations Benzinga

Oct 19, 2021

04:46PM EDT Intuitive Surgical Q3 EPS $1.04 Vs. $0.87 Year Ago RTTNews

04:12PM EDT Intuitive Surgical Inc. (ISRG) reported earnings for its third quarter that rose from last year. RTTNews

04:11PM EDT Intuitive Surgical Inc. (ISRG) announced a profit for its third quarter that increased from last year. RTTNews

02:50PM EDT Intuitive Surgical Names Jamie Samath CFO Benzinga

02:49PM EDT Intuitive Surgical Q3 EPS $1.19 Beats $1.17 Estimate, Sales $1.40B Beat $1.39B Estimate Benzinga

02:46PM EDT Intuitive (the Company) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended September30, 2021. All share and per-share information have been retroactively adjusted to reflect a three-for-one stock split. GlobeNewswire Inc

02:45PM EDT -- Marshall Mohr named new EVP for Global Business Services -- Jamie Samath named CFO -- Dave Rosa named new Chief Strategy and Growth Officer -- Henry Charlton named Chief Commercial Officer GlobeNewswire Inc

01:23PM EDT Intuitive Surgical Q3 Adj. EPS $1.19 Vs Est $1.19 Benzinga

08:23AM EDT The Daily Biotech Pulse: Entasis, Dermata Spike Higher On Positive Readouts, J&J Q3 EPS Beats Estimates, Wave Life Sciences Regains Right To CNS Portfolio Benzinga

04:06AM EDT Earnings Scheduled For October 19, 2021 Benzinga

Oct 18, 2021

02:11PM EDT Intuitive Surgical Earnings Preview Benzinga

09:18AM EDT Intuitive Announces PRECIsE Clinical Study Preliminary Results Favorable For Its Ion Endoluminal System For Peripheral Nodule Lung Biopsy Benzinga

09:05AM EDT Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announcedthe release of preliminary data from 69 subjects participating in the Prospective, Multi-Center Evaluation of the Clinical Utility (PRECIsE) a post-market, multi-center clinical trial of its Ion endoluminal system. GlobeNewswire Inc

07:34AM EDT The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs Benzinga

Oct 15, 2021

10:09AM EDT Price To Earnings Ratio Insights For Intuitive Surgical Benzinga

Oct 5, 2021

09:41AM EDT CORRECTION: Morgan Stanley Maintains Equal-Weight on Intuitive Surgical, Adjusts Price Target to $310 Benzinga

09:10AM EDT Morgan Stanley Maintains Equal-Weight on Intuitive Surgical, Lowers Price Target to $310 Benzinga

Oct 1, 2021

07:05AM EDT Citigroup Downgrades Intuitive Surgical to Neutral, Announces $1100 Price Target Benzinga

Sep 10, 2021

07:36PM EDT Intuitive Surgical Shares Move Sharply Lower; Co Says Guidance Did Not Contemplate Higher Supply Costs Or Impact Of COVID In U.S.; Says Now Seeing Them Both Benzinga

Sep 9, 2021

08:17AM EDT The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization Benzinga

Sep 8, 2021

07:32AM EDT The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod Benzinga

Sep 3, 2021

07:31AM EDT The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself Benzinga

Sep 2, 2021

08:20AM EDT The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab Benzinga

Aug 31, 2021

04:25PM EDT Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the appointment of Yong-Bum Choi as General Manager for South Korea, where he will direct business strategy and operations for the company. GlobeNewswire Inc

Aug 26, 2021

07:55AM EDT 10 Biggest Price Target Changes For Thursday Benzinga

04:47AM EDT SVB Leerink Maintains Market Perform on Intuitive Surgical, Raises Price Target to $1040 Benzinga

Aug 20, 2021

07:45AM EDT The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data Benzinga

Aug 19, 2021

10:57AM EDT The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck Benzinga

08:23AM EDT Cramer Shares His Thoughts On Skyworks Solutions, Canopy Growth Corp And More Benzinga

07:37AM EDT The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck Benzinga

Aug 18, 2021

07:38AM EDT The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline Benzinga

Aug 10, 2021

07:55AM EDT The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts Benzinga

Aug 6, 2021

07:42AM EDT The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO Benzinga

Aug 5, 2021

09:06AM EDT Intuitive Board of Directors Approves Three-For-One Stock Split; Stock To Begin Trading On Split-Adjusted Basis Oct. 5 Benzinga

08:08AM EDT The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO Benzinga

Aug 4, 2021

07:52AM EDT The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings Benzinga

Aug 3, 2021

07:55AM EDT The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business Benzinga

Jul 26, 2021

10:50AM EDT Return on Capital Employed Overview: Intuitive Surgical Benzinga

Jul 22, 2021

12:34PM EDT Expert Ratings For Intuitive Surgical Benzinga

11:34AM EDT The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, Absci IPO Benzinga

09:26AM EDT Deutsche Bank Maintains Hold on Intuitive Surgical, Raises Price Target to $925 Benzinga

08:18AM EDT The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO Benzinga

Jul 21, 2021

10:27AM EDT Wells Fargo Maintains Overweight on Intuitive Surgical, Raises Price Target to $1060 Benzinga

09:45AM EDT Intuitive Surgical shares were trading higher after the company reported better-than-expected Q2 EPS and sales results. Benzinga

08:44AM EDT Evercore ISI Group Maintains In-Line on Intuitive Surgical, Raises Price Target to $980 Benzinga

08:20AM EDT 10 Biggest Price Target Changes For Wednesday Benzinga

07:52AM EDT The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay Benzinga

07:43AM EDT Morgan Stanley Maintains Equal-Weight on Intuitive Surgical, Raises Price Target to $930 Benzinga

06:54AM EDT Citigroup Maintains Buy on Intuitive Surgical, Raises Price Target to $1100 Benzinga

06:04AM EDT A Peek Into The Markets: US Stock Futures Up Ahead Of Earnings Benzinga

04:29AM EDT SVB Leerink Maintains Market Perform on Intuitive Surgical, Raises Price Target to $975 Benzinga

Jul 20, 2021

04:23PM EDT Intuitive Surgical: Q2 Earnings Insights Benzinga

04:18PM EDT Intuitive Surgical Inc. (ISRG) announced a profit for its second quarter that rose from last year. RTTNews

04:12PM EDT Intuitive Surgical Q2 EPS $4.25 Vs. $0.57 Year Ago RTTNews

04:05PM EDT Intuitive (the Company) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended June30, 2021. GlobeNewswire Inc

04:04PM EDT Intuitive Surgical Q2 Adj. EPS $3.92 Beats $3.06 Estimate, Sales $1.46B Beat $1.26B Estimate Benzinga

08:20AM EDT The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street Benzinga

05:10AM EDT Earnings Scheduled For July 20, 2021 Benzinga

Jul 19, 2021

10:28AM EDT Preview: Intuitive Surgical's Earnings Benzinga

Jul 14, 2021

12:12PM EDT Where Intuitive Surgical Stands With Analysts Benzinga

07:49AM EDT 10 Biggest Price Target Changes For Wednesday Benzinga

07:48AM EDT The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues Benzinga

07:39AM EDT Stifel Maintains Buy on Intuitive Surgical, Raises Price Target to $1060 Benzinga

Jul 8, 2021

07:45AM EDT The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test Benzinga

Jul 7, 2021

07:41AM EDT The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend Benzinga

Jul 2, 2021

07:38AM EDT The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures Benzinga

Jun 30, 2021

07:29AM EDT The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs Benzinga

Jun 29, 2021

08:17AM EDT The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout Benzinga

Jun 25, 2021

07:32AM EDT The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs Benzinga

Jun 24, 2021

08:12AM EDT The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO Benzinga

Jun 23, 2021

07:35AM EDT The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway Benzinga

Jun 22, 2021

08:12AM EDT The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal Benzinga

Jun 7, 2021

12:00PM EDT Where Intuitive Surgical Stands With Analysts Benzinga

07:48AM EDT 10 Biggest Price Target Changes For Monday Benzinga

07:14AM EDT Wells Fargo Maintains Overweight on Intuitive Surgical, Raises Price Target to $916 Benzinga

Jun 1, 2021

11:10AM EDT Expert Ratings for Intuitive Surgical Benzinga

10:04AM EDT Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2021 Benzinga

07:20AM EDT Evercore ISI Group Upgrades Intuitive Surgical to In-Line, Announces $825 Price Target Benzinga

May 24, 2021

10:51AM EDT Where Intuitive Surgical Stands With Analysts Benzinga

08:41AM EDT Argus Research Maintains Buy on Intuitive Surgical, Raises Price Target to $900 Benzinga

Apr 26, 2021

08:45AM EDT Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the appointment of Dr.Monica P. Reed, a former AdventHealth executive, to its board of directors effective April 22, 2021. GlobeNewswire Inc

Apr 22, 2021

08:09AM EDT The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs Benzinga

Apr 21, 2021

01:59PM EDT Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2021 Benzinga

11:21AM EDT Intuitive Surgical Stock Is Trading Higher On Earnings Beat, As Easing Of COVID-19 Concerns Boosted Topline And Bottomline Growth Benzinga

10:37AM EDT A Look Into Intuitive Surgical's Price Over Earnings Benzinga

10:05AM EDT Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2021 Benzinga

09:27AM EDT Deutsche Bank Maintains Hold on Intuitive Surgical, Raises Price Target to $825 Benzinga

09:06AM EDT Citigroup Maintains Buy on Intuitive Surgical, Raises Price Target to $939 Benzinga

08:47AM EDT Morgan Stanley Maintains Equal-Weight on Intuitive Surgical, Raises Price Target to $855 Benzinga

08:46AM EDT Piper Sandler Maintains Neutral on Intuitive Surgical, Raises Price Target to $840 Benzinga

08:37AM EDT Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Apr. 21, 2021: NFLX, ROKU, ISRG, DGLY, WBT Benzinga

07:51AM EDT Oppenheimer Upgrades Intuitive Surgical to Perform Benzinga

07:42AM EDT 10 Biggest Price Target Changes For Wednesday Benzinga

07:31AM EDT The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue Benzinga

06:47AM EDT SVB Leerink Maintains Market Perform on Intuitive Surgical, Raises Price Target to $860 Benzinga

06:44AM EDT Baird Upgrades Intuitive Surgical to Outperform, Raises Price Target to $925 Benzinga

06:31AM EDT A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of Verizon Earnings Benzinga

Apr 20, 2021

04:16PM EDT Recap: Intuitive Surgical Q1 Earnings Benzinga

04:13PM EDT Intuitive Q1 EPS $3.51 Vs. $2.62 Year Ago RTTNews

04:12PM EDT Intuitive Surgical Inc. (ISRG) announced earnings for its first quarter that increased from last year. RTTNews

04:06PM EDT Intuitive Surgical Q1 Adj. EPS $3.52 Beats $2.63 Estimate, Sales $1.29B Beat $1.11B Estimate Benzinga

08:07AM EDT The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex Benzinga

04:02AM EDT Earnings Scheduled For April 20, 2021 Benzinga

Apr 19, 2021

10:23AM EDT Preview: Intuitive Surgical's Earnings Benzinga

Apr 1, 2021

10:46AM EDT Citigroup Initiates Coverage On Intuitive Surgical with Buy Rating, Announces Price Target of $862 Benzinga

Mar 31, 2021

09:21AM EDT Genius Brands Issues CEO Annual Letter (Full Letter) Benzinga

09:00AM EDT Piper Sandler Maintains Neutral on Intuitive Surgical, Raises Price Target to $735 Benzinga

Jan 22, 2021

09:01AM EST Raymond James Maintains Outperform on Intuitive Surgical, Raises Price Target to $865 Benzinga

Jan 21, 2021

05:05PM EST Intuitive Surgical: Q4 Earnings Insights Benzinga

04:29PM EST Intuitive Surgical Inc. (ISRG) announced a profit for its fourth quarter that rose from the same period last year. RTTNews

04:11PM EST Intuitive Q4 EPS $3.02 Vs. $2.99 Year Ago RTTNews

04:05PM EST Intuitive (the Company) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December31, 2020. Reported revenue and procedure results are consistent with the Companys press release issued on January 13, 2021. GlobeNewswire Inc

04:05PM EST Intuitive Surgical Q4 da Vinci Shipments 326, Down 3% Year Over Year, Installed 5,989 Systems, Up 7% YoY Benzinga

04:04PM EST Intuitive Surgical Q4 Adj. EPS $3.58 Beats $3.12 Estimate, Sales $1.33B Beat $1.24B Estimate Benzinga

04:13AM EST Earnings Scheduled For January 21, 2021 Benzinga

Jan 20, 2021

10:18AM EST A Preview Of Intuitive Surgical's Earnings Benzinga

Jan 13, 2021

10:15AM EST Intuitive Surgical Inc. (ISRG) expects fourth quarter 2020 revenue of about $1.33 billion, an increase of 4% from the prior year's $1.28 billion. Analysts polled by Thomson Reuters expect the company to report revenues of $1.23 billion for the fourth-quarter. Analysts' estimates typically exclude special items. RTTNews

09:09AM EST Intuitive Sees Prelim. Q4 Sales $1.33B vs $1.23B Est., Sees Prelim. FY20 Sales $4.48B vs $4.27B Est. Benzinga

09:09AM EST Intuitive Preliminary Q4 Revenue $1.33 Bln, Up 4% From $1.28 Bln Last Year RTTNews

09:05AM EST Intuitive (the Company) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2020 financial results ahead of its participation at the 39th Annual JP Morgan Healthcare Conference on January 11-14, 2021. GlobeNewswire Inc

Jan 4, 2021

10:25AM EST Bolder Surgical Launches CoolSeal Vessel Sealing Platform Benzinga

Dec 23, 2020

08:31AM EST The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut Benzinga

Dec 15, 2020

11:17AM EST Intuitive Surgical shares were trading lower after Morgan Stanley downgraded the stock from Overweight to Equal-Weight. Benzinga

09:42AM EST Benzinga's Top Upgrades, Downgrades For December 15, 2020 Benzinga

08:42AM EST Morgan Stanley Downgrades Intuitive Surgical to Equal-Weight Benzinga

Nov 10, 2020

08:40AM EST The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies Benzinga

Nov 2, 2020

10:36AM EST ROCE Insights For Intuitive Surgical Benzinga

Oct 27, 2020

08:08AM EDT Intuitive Launches $100M Venture Capital Fund Benzinga

08:00AM EDT Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the launch of Intuitive Ventures. The inaugural $100 million fund will invest in the future leaders of minimally invasive care. GlobeNewswire Inc

Oct 16, 2020

11:00AM EDT Intuitive Surgical shares are trading lower after the company reported its Q3 da Vinci shipments decreased 29% year over year and its Q3 revenue decreased 4% year over year. Benzinga

09:10AM EDT SVB Leerink Maintains Market Perform on Intuitive Surgical, Raises Price Target to $725 Benzinga

08:28AM EDT Morgan Stanley Maintains Overweight on Intuitive Surgical, Raises Price Target to $785 Benzinga

07:58AM EDT Wells Fargo Maintains Overweight on Intuitive Surgical, Raises Price Target to $815 Benzinga

06:05AM EDT A Peek Into The Markets: US Stock Futures Mixed Ahead Of Economic Reports Benzinga

Oct 15, 2020

05:26PM EDT 10 Stocks Moving In Thursday's After-Hours Session Benzinga

04:27PM EDT Recap: Intuitive Surgical Q3 Earnings Benzinga

04:11PM EDT Intuitive Surgical Inc. (ISRG) reported earnings for third quarter that dropped from last year. RTTNews

04:09PM EDT Intuitive Q3 EPS $2.60 Vs. $3.33 Year Ago RTTNews

04:08PM EDT Intuitive Surgical Reports Shipped 195 Da Vinci Surgical Systems In Q3, Down 29% YoY Benzinga

04:04PM EDT Intuitive Surgical Q3 da Vince Procedures Up ~7% Year Over Year, Shipped 195 Systems, Down 29% YoY Benzinga

04:03PM EDT Intuitive Surgical Q3 Adj. EPS $2.77 Beats $2.07 Estimate, Sales $1.08B Beat $970.97M Estimate Benzinga

04:08AM EDT Earnings Scheduled For October 15, 2020 Benzinga

Oct 14, 2020

10:20AM EDT Intuitive Surgical Earnings Preview Benzinga

Oct 12, 2020

07:47AM EDT Raymond James Maintains Outperform on Intuitive Surgical, Raises Price Target to $800 Benzinga

Sep 28, 2020

12:33PM EDT Argus Research Initiates Coverage On Intuitive Surgical with Buy Rating Benzinga

Sep 11, 2020

12:15PM EDT Wolfe Research Initiates Coverage On Intuitive Surgical with Outperform Rating, Announces Price Target of $789 Benzinga

Sep 8, 2020

12:43PM EDT B of A Securities Downgrades Intuitive Surgical to Neutral, Raises Price Target to $760 Benzinga

Sep 2, 2020

10:21AM EDT Benzinga's Top Upgrades, Downgrades For September 2, 2020 Benzinga

06:05AM EDT Baird Initiates Coverage On Intuitive Surgical with Neutral Rating, Announces Price Target of $700 Benzinga

Aug 14, 2020

08:50AM EDT 10 Biggest Price Target Changes For Friday Benzinga

06:56AM EDT SVB Leerink Maintains Market Perform on Intuitive Surgical, Raises Price Target to $690 Benzinga

Jul 22, 2020

06:10PM EDT Intuitive Surgical's Outlook 'Has Never Been Stronger,' Analyst Says After Q2 Report Benzinga

12:33PM EDT Stifel Maintains Buy on Intuitive Surgical, Raises Price Target to $725 Benzinga

11:08AM EDT Wells Fargo Maintains Overweight on Intuitive Surgical, Raises Price Target to $727 Benzinga

10:44AM EDT Intuitive Surgical Shares Quiet Following Beta.Sam.gov Contract Notice For Co.'s Da Vinci Surgical System Via US Dept. Of Veterans Affairs, No Terms Disclosed Benzinga

10:07AM EDT Canaccord Genuity Maintains Buy on Intuitive Surgical, Raises Price Target to $725 Benzinga

09:07AM EDT Deutsche Bank Maintains Hold on Intuitive Surgical, Raises Price Target to $600 Benzinga

08:34AM EDT 10 Biggest Price Target Changes For Wednesday Benzinga

08:21AM EDT Morgan Stanley Maintains Overweight on Intuitive Surgical, Raises Price Target to $735 Benzinga

08:06AM EDT UBS Maintains Neutral on Intuitive Surgical, Raises Price Target to $670 Benzinga

07:34AM EDT Raymond James Maintains Outperform on Intuitive Surgical, Raises Price Target to $725 Benzinga

07:13AM EDT Looking Into Intuitive Surgical's Return On Capital Employed Benzinga

06:24AM EDT A Peek Into The Markets: US Stock Futures Drop; Microsoft, Tesla Earnings In Focus Benzinga

06:04AM EDT SVB Leerink Maintains Market Perform on Intuitive Surgical, Raises Price Target to $650 Benzinga

Jul 21, 2020

04:13PM EDT Intuitive Surgical Inc. (ISRG) revealed earnings for second quarter that decreased from last year. RTTNews

04:12PM EDT Intuitive Q2 GAAP EPS $0.57 Vs $2.67 Last Year RTTNews

Jul 16, 2020

10:20AM EDT Intuitive Surgical Shares Spike Higher After Traders Circulate Goldman Note On Johnson & Johnson Saying J&J Confirms Delay In Robotic Surgery Program Benzinga

Jul 15, 2020

07:12AM EDT SVB Leerink Maintains Market Perform on Intuitive Surgical, Raises Price Target to $590 Benzinga